Bull
$247.22
Scenario price
$303.250
+1.395 (+0.46%)At close
Acuity Inc. is an industrial technology company. The Company uses technology to solve problems in space and light. The Company offers products and services, including lighting, lighting controls, building management solutions, and an audio, video, and control platform. The Company's segments include Acuity Brands Lighting (ABL) and Acuity Intelligent Spaces (AIS). The ABL segment includes portfolio of products includes, but is not limited to the following brands: AculuxTM, American Electric Lighting, CycloneTM, Dark to Light, eldoLED, Eureka, FrescoTM, Gotham, Healthcare Lighting, Holophane, Hydrel, IOTA, Juno, Lithonia Lighting, Luminaire LEDTM, Luminis, Mark Architectural LightingTM, NightingaleTM, nLight, Peerless, RELOC Wiring Solutions, and SensorSwitchTM. The AIS segment through Atrius, Distech Controls, and QSC, offers technologies used by people in spaces and by those who manage those spaces.
Acuity Brands Inc is currently priced at $303.25, which is below the average analyst price target of $390. However, the stock has a year-to-date change of -18.77%, indicating significant underperformance. The RSI is at 53.997, suggesting the stock is neither overbought nor oversold, and the forward P/E ratio of 14.1044 indicates it may be undervalued compared to its earnings potential. The main risk is the recent downgrade in price targets by analysts, with Baird lowering its target to $348, which could indicate a lack of confidence in short-term recovery.
Oppenheimer
$415
2026-10-08
Oppenheimer
2026-10-08
Price Target
$415
Baird
$348
2026-10-02
Baird
2026-10-02
Price Target
$348
Baird
$360
2026-09-29
Baird
2026-09-29
Price Target
$360
William Blair
—
2026-09-28
William Blair
2026-09-28
Price Target
—
Baird
$390
2026-06-26
Baird
2026-06-26
Price Target
$390
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Significant Stock Movements for Multiple Companies

Acuity Inc. to Release Fiscal 2026 Results on October 1

Two Profitable Stocks with Competitive Advantages

Three Market-Beating Stocks to Target This Week

Acuity's Q3 Earnings Call Highlights Stabilizing Demand and Growth in Intelligent Spaces
Acuity Inc. is an industrial technology company. The Company uses technology to solve problems in space and light. The Company offers products and services, including lighting, lighting controls, building management solutions, and an audio, video, and control platform. The Company's segments include Acuity Brands Lighting (ABL) and Acuity Intelligent Spaces (AIS). The ABL segment includes portfolio of products includes, but is not limited to the following brands: AculuxTM, American Electric Lighting, CycloneTM, Dark to Light, eldoLED, Eureka, FrescoTM, Gotham, Healthcare Lighting, Holophane, Hydrel, IOTA, Juno, Lithonia Lighting, Luminaire LEDTM, Luminis, Mark Architectural LightingTM, NightingaleTM, nLight, Peerless, RELOC Wiring Solutions, and SensorSwitchTM. The AIS segment through Atrius, Distech Controls, and QSC, offers technologies used by people in spaces and by those who manage those spaces. It operates in the Consumer Cyclicals sector (ELECTRIC LIGHTING & WIRING EQUIPMENT industry).
Acuity Brands Inc is currently priced at $303.25, which is below the average analyst price target of $390. However, the stock has a year-to-date change of -18.77%, indicating significant underperformance. The RSI is at 53.997, suggesting the stock is neither overbought nor oversold, and the forward P/E ratio of 14.1044 indicates it may be undervalued compared to its earnings potential. The main risk is the recent downgrade in price targets by analysts, with Baird lowering its target to $348, which could indicate a lack of confidence in short-term recovery.
16 analysts cover AYI: 7 rate it Buy, 8 Hold and 1 Sell. The average price target is 401.25.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.